Research Roundup: October/November 2017

Featured Article

Research Roundup: October/November 2017

The latest medical news for people with allergies and food sensitivities.

A new study on peanut immunotherapy examined the effects of increasing the peanut protein threshold (called the eliciting dose) used with the Viaskin Peanut patch. Developed by DBV Technologies, the Viaskin Peanut patch delivers biologically active compounds to the immune system through intact skin. It is currently in Phase III trials and not offered for sale.

Read more >

Articles